Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2008 1
2012 2
2013 2
2014 2
2016 4
2017 1
2018 1
2019 1
2020 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.
Murata A, Amano N, Sato S, Tsuzura H, Tomishima K, Sato S, Matsumoto K, Shimada Y, Iijima K, Genda T. Murata A, et al. Among authors: iijima k. Int J Mol Sci. 2020 Mar 17;21(6):2051. doi: 10.3390/ijms21062051. Int J Mol Sci. 2020. PMID: 32192084 Free PMC article.
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.
Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Murata A, et al. Among authors: iijima k. World J Gastroenterol. 2016 Sep 7;22(33):7569-78. doi: 10.3748/wjg.v22.i33.7569. World J Gastroenterol. 2016. PMID: 27672277 Free PMC article.
17 results